A New Perspective on Oncology Therapeutics

thumbnail_fotolia_97859909_subscription_monthly_m

GBI Research has built up a portfolio of compelling business intelligence reports showcasing progressive and data-driven analysis across the oncology therapy area. Our reports combine innovative analytical methodologies leveraging industry-leading databases, with authoritative commentary and novel insights.

Oncology has more pipeline activity than any other therapy area across the industry

GBI Research has an extensive range of reports exploring this activity and innovation across different indications and disease areas.

untitled

Reports Include:

Ocular Cancer Drug Development Pipeline Review, 2018    
Single user price:
$3,995

Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018    
Single user price:
$3,995

Breast Cancer Therapeutics in Asia-Pacific Markets to 2024 – Growth Driven by Increasing Uptake of Targeted Therapies and Rising Prevalence    
Single user price:
$4,995

Global Cancer Immunotherapies Market to 2024 – Increased Uptake of Immune Checkpoint Inhibitors Driving Growth, Supported by a Large, Robust Pipeline    
Single user price:
$4,995

Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2024 – Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market    
Single user price:
$4,995

Frontier Pharma: Breast Cancer – First-in-Class Innovation Underlies Immunotherapeutic Potential and Pipeline Diversification for Late-Stage Breast Cancer
Single user price:
$6,995

 

Report Information:
Published: 2018
Publisher: GBI Research
Report Format: electronic pdf

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s